首页> 外文期刊>Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis >Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease.
【24h】

Successful use of recombinant factor VIII devoid of von Willebrand factor during multiple teeth extractions in a patient with type 3 von Willebrand disease.

机译:在患有3型von Willebrand病的患者多次拔牙过程中成功使用不含von Willebrand因子的重组因子VIII。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We report a 55-year-old patient with type 3 von Willebrand disease who underwent multiple tooth extractions with successful hemostatic management using recombinant factor VIII. The patient was previously misdiagnosed and treated incorrectly then at 53 years old, he was diagnosed with type 3 von Willebrand disease. As he had avoided dental treatments for two decades due to severe bleeding after dental extraction, multiple severe caries and marginal periodontitis were revealed. The patient refused the use of blood products in hemostatic management because he was afraid of blood-borne diseases and development of anti-von Willebrand factor alloantibodies. After close consultation, we therefore decided to use recombinant factor VIII. Four teeth extraction procedures were executed twice. Before extraction, bolus recombinant factor VIII (50 IU/kg) was administered intravenously followed by continuous infusion (5-10 IU/kg per h) for approximately 48 h. The factor VIII:C level increased from about 1 to 20-32% 30 min after bolus infusion. During continuous infusion (10 IU/kg/h), factor VIII:C was maintained at more than 10%. Little bleeding occurred during and after the multiple teeth extractions and during suture removal. On frequent examinations during a 1-year follow-up, neither von Willebrand factor nor factor VIII inhibitors were detected.
机译:我们报道了一名55岁的3型von Willebrand病患者,该患者接受了多次拔牙,并使用重组因子VIII成功地止血。该患者先前被误诊并接受了不正确的治疗,然后在53岁时被诊断出患有3型von Willebrand病。由于他由于拔牙后出现严重出血而避免了牙科治疗二十年,因此发现了多发严重龋齿和边缘性牙周炎。该患者拒绝在止血管理中使用血液制品,因为他担心血液传播疾病和抗von Willebrand因子同种抗体的发展。经过密切协商,我们决定使用重组凝血因子VIII。两次执行四个拔牙程序。提取前,静脉内推注重组VIII因子(50 IU / kg),然后连续输注(5-10 IU / kg / h)约48 h。推注后30分钟,凝血因子VIII:C的水平从约1增加到20-32%。在连续输注(10 IU / kg / h)期间,凝血因子VIII:C维持在10%以上。在拔除多颗牙齿的过程中和拔除缝线后,出血很少。在为期1年的随访中,频繁检查未发现von Willebrand因子和VIII因子抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号